Sign In
Buy RXST
$4.79
-0.150 (-3.04%)
At Close: Jun 03, 2026
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter
07:16am, Friday, 09'th May 2025
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript
11:04pm, Wednesday, 07'th May 2025
RxSight, Inc. (NASDAQ:RXST ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Oliver Moravcevic - Vice President, Investor Relations Ron Kurtz - President & Chief Executive
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates
09:00pm, Wednesday, 07'th May 2025
RxSight, Inc. (RXST) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.12 per share a year ago.
RxSight, Inc. to Present at the Bank of America Healthcare Conference
04:05pm, Wednesday, 30'th Apr 2025
ALISO VIEJO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followin
RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
11:05am, Wednesday, 30'th Apr 2025
RxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RxSight price target lowered to $17 from $22 at Wells Fargo
06:27am, Monday, 07'th Apr 2025
Wells Fargo lowered the firm's price target on RxSight to $17 from $22 and keeps an Equal Weight rating on the shares following the conference call to discuss the preliminary Q1 2025 sales results and
RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade)
05:57pm, Thursday, 03'rd Apr 2025
RxSight posted a sequential revenue decline, revealing cracks in momentum despite earlier signs of profitability. Revised 2025 outlook and lack of expected profitability suggest earlier optimism was p
RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript)
03:54pm, Thursday, 03'rd Apr 2025
RxSight, Inc. (NASDAQ:RXST ) Q1 2025 Preliminary Results Conference Call April 3, 2025 8:00 AM ET Company Participants Oliver Moravcevic - VP, IR Dr. Ron Kurtz - Director, Co-President and CEO Shelley
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
08:00pm, Wednesday, 02'nd Apr 2025
ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients follow
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
04:05pm, Tuesday, 25'th Mar 2025
ALISO VIEJO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followin
RxSight, Inc. (RXST) Q4 2024 Earnings Call Transcript
06:35am, Wednesday, 26'th Feb 2025
RxSight, Inc. (NASDAQ:RXST ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Oliver Moravcevic - VP, IR Ron Kurtz - President and CEO Shelley Thunen - CFO Conference
RxSight, Inc. (RXST) Misses Q4 Earnings Estimates
06:56pm, Tuesday, 25'th Feb 2025
RxSight, Inc. (RXST) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to loss of $0.26 per share a year ago.
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance
04:05pm, Tuesday, 25'th Feb 2025
ALISO VIEJO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followin
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
04:05pm, Thursday, 02'nd Jan 2025
ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followin
